• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生理药代动力学(PBPK)模型的种间外推替代方法可减少动物使用:一项系统评价。

PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review.

作者信息

Lancheros Porras Karen Dayana, Alves Izabel Almeida, Novoa Diana Marcela Aragón

机构信息

Departamento de Farmacia, Universidad Nacional de Colombia, Bogotá D.C., Colombia.

Department of Pharmacy, Federal University of Bahia, Salvador, BA, Brazil.

出版信息

Curr Med Chem. 2024;31(1):102-126. doi: 10.2174/0929867330666230408201849.

DOI:10.2174/0929867330666230408201849
PMID:37031391
Abstract

INTRODUCTION

Physiologically based pharmacokinetic (PBPK) modeling is a computational approach that simulates the anatomical structure of the studied species and presents the organs and tissues as compartments interconnected by arterial and venous blood flows.

AIM

The aim of this systematic review was to analyze the published articles focused on the development of PBPK models for interspecies extrapolation in the disposition of drugs and health risk assessment, presenting to this modeling an alternative to reduce the use of animals.

METHODS

For this purpose, a systematic search was performed in PubMed using the following search terms: "PBPK" and "Interspecies extrapolation". The revision was performed according to PRISMA guidelines.

RESULTS

In the analysis of the articles, it was found that rats and mice are the most commonly used animal models in the PBPK models; however, most of the physiological and physicochemical information used in the reviewed studies were obtained from previous publications. Additionally, most of the PBPK models were developed to extrapolate pharmacokinetic parameters to humans and the main application of the models was for toxicity testing.

CONCLUSION

PBPK modeling is an alternative that allows the integration of in vitro and in silico data as well as parameters reported in the literature to predict the pharmacokinetics of chemical substances, reducing in large quantity the use of animals that are required in traditional studies.

摘要

引言

基于生理的药代动力学(PBPK)建模是一种计算方法,可模拟所研究物种的解剖结构,并将器官和组织呈现为由动脉和静脉血流相互连接的隔室。

目的

本系统评价的目的是分析已发表的文章,这些文章聚焦于开发用于药物处置种间外推和健康风险评估的PBPK模型,为该建模方法提供一种减少动物使用的替代方案。

方法

为此,在PubMed中使用以下检索词进行了系统检索:“PBPK”和“种间外推”。根据PRISMA指南进行综述。

结果

在对文章的分析中发现,大鼠和小鼠是PBPK模型中最常用的动物模型;然而,综述研究中使用的大多数生理和物理化学信息均来自以前的出版物。此外,大多数PBPK模型是为将药代动力学参数外推至人类而开发的,且模型的主要应用是用于毒性测试。

结论

PBPK建模是一种替代方法,它允许整合体外和计算机模拟数据以及文献中报道的参数,以预测化学物质的药代动力学,大量减少传统研究所需的动物使用。

相似文献

1
PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review.基于生理药代动力学(PBPK)模型的种间外推替代方法可减少动物使用:一项系统评价。
Curr Med Chem. 2024;31(1):102-126. doi: 10.2174/0929867330666230408201849.
2
Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.基于生理学的药代动力学(PBPK)模型评估全氟辛烷磺酸(PFOS)在小鼠、大鼠、猴子和人类之间的种间不确定性:开发和性能验证。
Environ Int. 2019 Aug;129:408-422. doi: 10.1016/j.envint.2019.03.058. Epub 2019 May 29.
3
Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation.金纳米颗粒在小鼠体内的生物分布及基于生理的药代动力学建模与种间外推
Pharmaceutics. 2019 Apr 12;11(4):179. doi: 10.3390/pharmaceutics11040179.
4
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.基于生理的药代动力学(PBPK)建模与模拟方法:对已发表模型、应用及模型验证的系统综述
Drug Metab Dispos. 2015 Nov;43(11):1823-37. doi: 10.1124/dmd.115.065920. Epub 2015 Aug 21.
5
Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials.基于生理学的纳米材料药代动力学(PBPK)建模进展。
ACS Pharmacol Transl Sci. 2024 Jul 12;7(8):2251-2279. doi: 10.1021/acsptsci.4c00250. eCollection 2024 Aug 9.
6
A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans.在小鼠中,一种基于生理的阿维泊霉素药代动力学模型及其向大鼠和人类的外推。
Br J Pharmacol. 2014 Jun;171(11):2778-89. doi: 10.1111/bph.12609.
7
Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.基于生理的药代动力学(PBPK)模型在肿瘤药物研发中的应用及其准确性:一项系统综述。
Eur J Clin Pharmacol. 2018 Nov;74(11):1365-1376. doi: 10.1007/s00228-018-2513-6. Epub 2018 Jul 5.
8
PBPK models in risk assessment--A focus on chloroprene.风险评估中的生理药代动力学(PBPK)模型——以氯丁二烯为重点
Chem Biol Interact. 2007 Mar 20;166(1-3):352-9. doi: 10.1016/j.cbi.2007.01.016. Epub 2007 Feb 8.
9
Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.用于毒理学和风险评估的基于生理的药代动力学和基于生理的药效学模型的开发。
Toxicol Lett. 1995 Sep;79(1-3):35-44. doi: 10.1016/0378-4274(95)03355-o.
10
Interspecies extrapolation.种间外推
Methods Mol Biol. 2012;929:501-20. doi: 10.1007/978-1-62703-050-2_19.

引用本文的文献

1
A Bottom-up Approach for Mutant and Wild Type Collies Using Physiologically Based Pharmacokinetic (PBPK) Modeling: A Case Study Using Loperamide.一种基于生理药代动力学(PBPK)模型的自下而上方法用于突变型和野生型柯利犬:以洛哌丁胺为例的案例研究
AAPS J. 2025 Jun 2;27(4):101. doi: 10.1208/s12248-025-01061-6.
2
The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases.药物计量学在推进自身免疫性疾病治疗中的作用。
Pharmaceutics. 2024 Dec 5;16(12):1559. doi: 10.3390/pharmaceutics16121559.